stock
CDNA · CareDx, Inc.
What CareDx, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live CDNA price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on CDNA.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Services-Medical Laboratories (SIC 8071)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 51,734,223 as of 2026-07-27 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- 23.6%
- Net
- 24.2%
Returns
- ROE
- 26.1%
- ROA
- 20.8%
Health
- Current ratio
- 4.6x
- Debt/equity
- —
Deep value
- NCAV
- $321.83M
- NCAV per share
- $6.22
- Price/NCAV
- Locked
- NNWC
- $295.52M
- NNWC per share
- $5.71
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $131.95M | — | $113.22M | $110.64M | 10-Q filed 2026-07-30 |
| 2026-03-31 | $117.70M | — | $1.20M | $2.81M | 10-Q filed 2026-07-30 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | $108.39M | — | -$6.04M | -$4.11M | DEF 14A filed 2026-04-27 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | $100.06M | — | -$246,000 | $1.68M | 10-Q filed 2025-11-04 |
| 2025-06-30 | $86.68M | — | -$11.12M | -$8.57M | 10-Q filed 2026-07-30 |
| 2025-03-31 | $84.69M | — | -$13.37M | -$10.35M | 10-Q filed 2026-07-30 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | $86.58M | — | $84.38M | $87.70M | DEF 14A filed 2026-04-27 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | $82.88M | — | -$13.72M | -$10.64M | 10-Q filed 2025-11-04 |
- Assets
- $532.99M
- Equity
- $425.60M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $379.81M | -$30.78M | -$21.35M | — |
| 2024-12-31 | $333.79M | $40.77M | $52.55M | — |
| 2023-12-31 | $280.32M | -$203.36M | -$190.28M | — |
| 2022-12-31 | $321.79M | -$77.23M | -$76.61M | — |
| 2021-12-31 | $296.40M | -$29.73M | -$30.66M | — |
| 2020-12-31 | $192.19M | -$22.53M | -$18.71M | — |
| 2019-12-31 | $127.07M | -$24.53M | -$21.97M | — |
| 2018-12-31 | $76.57M | -$15.58M | -$46.76M | -$6.04M |
| 2017-12-31 | $48.32M | -$20.29M | -$55.47M | -$14.49M |
| 2016-12-31 | $40.63M | -$37.33M | -$39.47M | -$17.07M |
Company filings
since Tue Apr 28
events
Acquisition or sale completed
Acquisition or sale completedSep 168-K/AResults, Regulation FD disclosure
ResultsRegulation FD disclosureJul 308-KAcquisition or sale completed, Regulation FD disclosure
Acquisition or sale completedRegulation FD disclosureJul 78-KExecutive or director change, Shareholder vote results
Executive or director changeShareholder vote resultsJun 158-KMaterial agreement, Results, Regulation FD disclosure, Other event
Material agreementResultsRegulation FD disclosureOther eventApr 288-KExecutive or director change
Executive or director changeApr 238-K/A
5% owners ()
BAMCO INC /NY/
Stake update
Gagnon Securities LLC
Stake update
STATE STREET CORPORATION
Passive stake
BlackRock, Inc.
Stake update
The Vanguard Group
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Bickerstaff George
Director
Sale$925,700Aug 6, 4:10 PM ET
COURNOYER CHRISTINE
Director
Sale$750,973Aug 6, 4:10 PM ET
Novack Jeffrey Adam
Secretary and General Counsel
Sale$124,349Aug 6, 4:05 PM ET
Goldberg Michael
Director
Sale$2,103,497Aug 6, 4:05 PM ET
Hanna John Walter JR
President and CEO, Director
Sale$4,458,637Jul 17, 4:23 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
- ARK Investment Management
Period Tue 30 Jun 2026
0.4%Trimmed - First Eagle
Period Tue 30 Jun 2026
0.0%Added
News
Stories that named CDNA, and the market events around them.
Sign in to see thisBoard
The CDNA board could not be loaded.
Retry the CDNA boardnakagai
Signals on CDNA come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the CDNA board